[Asia Economy Reporter Park Jihwan] PanGen announced on the 12th that it has signed a service contract worth 280 million KRW with Evicsgen related to new drug development. This corresponds to 16.7% of recent sales revenue.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
